UCFA
MGNX icon

United Capital Financial Advisors’s MacroGenics MGNX Stock Holding History

United Capital Financial Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,983
Closed -$303K – 1289
2015
Q2 		$303K Buy
+7,983
New +$262K ﹤0.01% 1065

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

United Capital Financial Advisors's MGNX Position: Q3 2015 in Review

United Capital Financial Advisors sold out of MacroGenics (MGNX) in Q3 2015, closing a stake of 7,983 shares — an estimated $303K sold.

United Capital Financial Advisors first reported a position in MGNX in Q2 2015 and held it in 1 quarter. The position peaked at $303K in Q2 2015. 125 funds tracked by Wall St. Rank hold MGNX as of Q3 2015.

  • United Capital Financial Advisors reported no remaining MacroGenics position as of Q3 2015 after selling out during the quarter.
  • United Capital Financial Advisors sold 7,983 MacroGenics shares in Q3 2015, an estimated $303K.
  • United Capital Financial Advisors first reported a position in MacroGenics in Q2 2015 and held it in 1 quarter.
  • United Capital Financial Advisors's MacroGenics position peaked at $303K in Q2 2015.
  • 125 funds tracked by Wall St. Rank held MacroGenics as of Q3 2015.

Based on United Capital Financial Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.